Lumira Ventures

Activity from announced rounds

Activity in this selectionSeries B
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$184.5M
3 disclosed · full round size, not this investor’s share

By stage

Series B3

By primary sector

Biotech2
Healthtech1

By country

United States2
Canada1

Rounds

3 in this selection
Contraline

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries B
Role not disclosed
Nervonik

Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions

$52.5MSeries B
Role not disclosed